The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptide

Behav Pharmacol. 2013 Feb;24(1):74-7. doi: 10.1097/FBP.0b013e32835cf3e5.

Abstract

Previous studies suggest that metabotropic glutamate 2/3 receptors are involved in psychiatric disorders. In this study, we examined the effects of the selective metabotropic glutamate 2/3 (mGlu2/3) receptor agonist MGS0028 on behavioral abnormalities in mice lacking the pituitary adenylate cyclase-activating polypeptide (PACAP), an experimental model of psychiatric disorders such as schizophrenia and attention-deficit/hyperactivity disorder. We found that PACAP-deficient mice showed impairments in the novel object recognition test and these impairments were improved by MGS0028 (0.1 mg/kg). Similarly, MGS0028 improved hyperactivity and jumping behaviors, but did not reverse increased immobility times in the forced swim test in PACAP-deficient mice. These results suggest that MGS0028 may be a potential, novel treatment for psychiatric disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipsychotic Agents / therapeutic use*
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / metabolism
  • Behavior, Animal / drug effects
  • Brain / drug effects
  • Brain / metabolism
  • Bridged Bicyclo Compounds / therapeutic use*
  • Dicarboxylic Acids / therapeutic use*
  • Disease Models, Animal
  • Male
  • Memory Disorders / drug therapy*
  • Memory Disorders / metabolism
  • Mice
  • Mice, Mutant Strains
  • Molecular Targeted Therapy
  • Nerve Tissue Proteins / agonists
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Nootropic Agents / therapeutic use*
  • Pituitary Adenylate Cyclase-Activating Polypeptide / genetics
  • Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism*
  • Receptors, Metabotropic Glutamate / agonists*
  • Receptors, Metabotropic Glutamate / metabolism
  • Recognition, Psychology / drug effects

Substances

  • Adcyap1 protein, mouse
  • Antipsychotic Agents
  • Bridged Bicyclo Compounds
  • Dicarboxylic Acids
  • Nerve Tissue Proteins
  • Nootropic Agents
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor 2
  • metabotropic glutamate receptor 3
  • MGS 0028